article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require the analysis of massive amounts of data. This knowledge enabled cell line engineering campaigns that boosted yield and stability across various production bottlenecks.

article thumbnail

Bioinformatics Jobs: How to Succeed in This Competitive Space

XTalks

The Human Genome Project could not have succeeded without the use of bioinformatics. The minimum requirement to become a professional in the bioinformatics field includes having a bachelor’s and master’s degree in bioinformatics, computer engineering, computational biology, computer science, or related field.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. Verily’s Immune Profiler can, Kim asserted, “generate more than 8 million immune measures across 24 immune cell subsets”. What, then, is the solution?

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

Researchers from the University of Oslo, University of Chicago Pritzker School of Medicine, and Insilico Medicine used an AI target discovery engine to analyse transcriptomic data to identify dual targets for cancer and ageing 5.

article thumbnail

Building the hospital of the future

pharmaphorum

Sitting at the center of the convergence between digital innovation, big data, and shifting stakeholder demands is the emerging trend of hospitals without walls, in which hospitals represent a digitally connected community rather than a circumscribed physical space. based healthcare, robotics, and 3D printing of tissues and implants.”

article thumbnail

The DDW Podcast: 2023 in review

Drug Discovery World

In September, Shelley Ackerman, a biological engineer turned immunologist with a passion for drug discovery and development, spoke about the work being carried out at Bolt BioTherapeutics, where she is the Director & Program Team Lead. A deep dive into US drug discovery What lies in the future for genomics and big data?

article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. He holds an MS degree in Statistics and a BS-equivalent in Bioengineering.